Company news
Daewoong Pharmaceutical Co., Ltd. (KRX:069620) news
Daewoong Pharmaceutical Co., Ltd. news releases on 6ix. Latest, May 4, 2026: FreeMind Investments and Daewoong Pharmaceutical Co., Ltd. Invest in General…
Press releases & updates
FreeMind Investments and Daewoong Pharmaceutical Co., Ltd. Invest in General Proximity
May 4, 2026
Daewoong Pharmaceutical Hosts 'NABOTA Master Class'… Highlighting Safety Amid Growing Demand for High-Dose, Repetitive Treatments
April 24, 2026
AEON Biopharma Announces Execution of Exchange Agreement with Daewoong
December 15, 2025
Daewoong Pharmaceutical: Third IDMC Reaffirms Safety of Bersiporocin and Recommends Continuation of Global Phase 2 Clinical Trial
October 27, 2025
Daewoong Therapeutics Microneedle Patch Achieves Best-in-Class Bioavailability, Proving the Strength of Its Drug-Delivery Platform
August 13, 2025
Salipro Biotech and Daewoong Pharmaceutical Announce Collaboration Agreement to Advance Development of Novel Therapeutics
June 10, 2025
Daewoong Pharmaceutical Presents Phase 2 Clinical Trial Poster on 'Bersiporocin' at ATS 2025, Highlights Global Patient Demographics
June 2, 2025